Arvinas Inc
NASDAQ:ARVN

Watchlist Manager
Arvinas Inc Logo
Arvinas Inc
NASDAQ:ARVN
Watchlist
Price: 25.86 USD 2.99% Market Closed
Market Cap: 1.8B USD
Have any thoughts about
Arvinas Inc?
Write Note

Relative Value

The Relative Value of one ARVN stock under the Base Case scenario is 11.88 USD. Compared to the current market price of 25.86 USD, Arvinas Inc is Overvalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ARVN Relative Value
Base Case
11.88 USD
Overvaluation 54%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
14
Median 3Y
13.9
Median 5Y
28.4
Industry
2.5
Forward
6.7
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-10.1
Industry
21.9
Forward
-7.9
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-8.3
Industry
16.5
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-8.2
Industry
23.6
vs History
69
vs Industry
24
Median 3Y
3.4
Median 5Y
4.5
Industry
2.1
vs History
76
vs Industry
28
Median 3Y
5.7
Median 5Y
19.6
Industry
2.6
Forward
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.2
vs History
vs Industry
55
Median 3Y
-2.4
Median 5Y
-6.2
Industry
13.3
Forward
-2.6
vs History
vs Industry
52
Median 3Y
-2.3
Median 5Y
-6
Industry
16.6
Forward
-2.3
vs History
vs Industry
52
Median 3Y
-1.1
Median 5Y
-3.1
Industry
15.6
vs History
vs Industry
39
Median 3Y
-1.1
Median 5Y
-3.1
Industry
19.1
vs History
vs Industry
4
Median 3Y
15
Median 5Y
32.5
Industry
1.9

Multiples Across Competitors

ARVN Competitors Multiples
Arvinas Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Arvinas Inc
NASDAQ:ARVN
1.8B USD 6.3 -3.4 -1.1 -1.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Arvinas Inc
NASDAQ:ARVN
Average P/E: 32.4
Negative Multiple: -3.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top